| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| UNII: | ONX021SC9O |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| CROSS-LINKING AGENT | Interleukin-18 cross-linking agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Pulmonary Disease, Chronic Obstructive | 1 | D029424 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
| Still's Disease, Adult-Onset | 1 | D016706 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109604 |
| FDA SRS | ONX021SC9O |
CONTENTS